Published in Oncogene on September 14, 2009
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell (2012) 4.09
Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer (2013) 2.02
FoxM1: a master regulator of tumor metastasis. Cancer Res (2011) 1.85
Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle (2011) 1.74
FOX(M1) news--it is cancer. Mol Cancer Ther (2013) 1.64
Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev (2009) 1.63
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance. Mol Cancer Ther (2011) 1.32
The transcription factor p53: not a repressor, solely an activator. Cell Cycle (2014) 1.23
Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene (2011) 1.23
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. Blood (2012) 1.20
The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes. Nucleic Acids Res (2015) 1.19
Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes. Mol Cancer (2010) 1.16
Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage. PLoS One (2012) 1.15
Novel functions of FoxM1: from molecular mechanisms to cancer therapy. Front Oncol (2013) 1.13
Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells. PLoS One (2011) 1.11
Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1. EMBO Rep (2010) 1.09
The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. Mol Cancer Res (2012) 0.98
FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim Biophys Acta (2014) 0.95
Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. J Pathol (2014) 0.94
p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies. J Biol Chem (2011) 0.90
Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis. Neoplasia (2014) 0.89
Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin. Cancer Biol Ther (2010) 0.88
FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta (2014) 0.88
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Endocr Relat Cancer (2012) 0.87
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways. Oncotarget (2014) 0.86
Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy. Oncotarget (2013) 0.86
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells. Int J Mol Sci (2014) 0.86
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Oncotarget (2014) 0.84
Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Oncotarget (2015) 0.83
Mechanism of cancer cell death induced by depletion of an essential replication regulator. PLoS One (2012) 0.83
Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol Cancer Ther (2013) 0.83
Rad53 downregulates mitotic gene transcription by inhibiting the transcriptional activator Ndd1. Mol Cell Biol (2013) 0.82
ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival. PLoS One (2012) 0.82
PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model. Leukemia (2014) 0.80
FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways. Oncotarget (2016) 0.79
The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy. Int J Breast Cancer (2016) 0.79
p53 Interacts with RNA polymerase II through its core domain and impairs Pol II processivity in vivo. PLoS One (2011) 0.79
Multiple facets of p53 in senescence induction and maintenance. Cancer Sci (2016) 0.79
Damaged DNA binding protein 2 in reactive oxygen species (ROS) regulation and premature senescence. Int J Mol Sci (2012) 0.78
Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors. Scientifica (Cairo) (2014) 0.76
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer. Oncol Lett (2017) 0.75
TBP-like protein (TLP) disrupts the p53-MDM2 interaction and induces long-lasting p53 activation. J Biol Chem (2017) 0.75
FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop. Oncotarget (2016) 0.75
Plk1 Regulates the Repressor Function of FoxM1b by inhibiting its Interaction with the Retinoblastoma Protein. Sci Rep (2017) 0.75
Downregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell line. Biomed Rep (2017) 0.75
FOXM1 in Cancer: Interactions and Vulnerabilities. Cancer Res (2017) 0.75
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat (2007) 12.98
Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol (2008) 11.05
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma (1997) 11.04
Genomic targets of the human c-Myc protein. Genes Dev (2003) 9.67
Regulation of the G2/M transition by p53. Oncogene (2001) 7.02
FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol (2005) 7.02
Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol (2005) 4.80
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem (2001) 4.21
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev (1996) 3.98
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev (2004) 3.91
Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell (2008) 3.75
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer (2007) 3.57
Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ (2006) 3.53
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res (2006) 3.28
DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene (2001) 3.28
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res (2005) 3.23
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia (2005) 3.16
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene (2002) 3.12
FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta (2006) 2.98
The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci U S A (2002) 2.93
Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res (2006) 2.92
The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res (2007) 2.92
MDM2, an introduction. Mol Cancer Res (2003) 2.87
The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res (2006) 2.84
FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res (2002) 2.71
Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res (2007) 2.71
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol (2008) 2.68
p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol (2005) 2.65
p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem (2003) 2.43
Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ (2003) 2.30
The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis. Dev Biol (2004) 2.19
The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol (2006) 2.15
Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol (2005) 2.13
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol Cell Biol (2006) 2.11
A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest (2006) 2.02
Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression. J Biol Chem (2006) 2.01
p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol (2001) 1.93
Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene (2003) 1.79
Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. J Biol Chem (2001) 1.73
p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis. J Biol Chem (2004) 1.70
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol (2008) 1.68
p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J Biol Chem (1999) 1.65
DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Mol Cell (2004) 1.53
Definition of the p53 functional domains necessary for inducing apoptosis. J Biol Chem (2000) 1.52
Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene (2006) 1.46
Anaphase-promoting complex/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol (2008) 1.42
p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. J Cell Sci (2005) 1.39
p53-dependent down-regulation of telomerase is mediated by p21waf1. J Biol Chem (2004) 1.39
The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res (2000) 1.36
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene (2002) 1.35
Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem (2000) 1.31
p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett (2005) 1.31
Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis (2007) 1.29
FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27 kip1. J Pathol (2009) 1.27
P53 promoter selection: choosing between life and death. Cell Cycle (2007) 1.25
Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J Biol Chem (2003) 1.23
p130/E2F4 binds to and represses the cdc2 promoter in response to p53. J Biol Chem (2000) 1.22
C-Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia. Hepatology (2008) 1.22
Global genechip profiling to identify genes responsive to p53-induced growth arrest and apoptosis in human lung carcinoma cells. Cancer Biol Ther (2003) 1.20
FoxM1c counteracts oxidative stress-induced senescence and stimulates Bmi-1 expression. J Biol Chem (2008) 1.19
Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol Cell Biol (2000) 1.18
Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol (2006) 1.16
Deciphering transcriptional regulatory elements that encode specific cell cycle phasing by comparative genomics analysis. Cell Cycle (2005) 1.12
p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog (2006) 1.12
The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding. Mol Cell Biol (2005) 1.10
Transcriptional up-regulation of FoxM1 in response to hypoxia is mediated by HIF-1. J Cell Biochem (2009) 1.07
Microarray expression profiling of p53-dependent transcriptional changes in an immortalized mouse embryo fibroblast cell line. Cancer Biol Ther (2003) 1.02
Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. J Cell Physiol (2009) 1.01
p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology (2009) 0.99
The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53. Cell Cycle (2006) 0.98
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis. J Biol Chem (2006) 0.92
Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Differ (1997) 0.92
Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem Biophys Res Commun (2001) 0.87
p53: puzzle and paradigm. Genes Dev (1996) 13.16
Wild-type p53 activates transcription in vitro. Nature (1992) 11.39
Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (1998) 10.89
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell (1997) 10.52
Identification of p53 as a sequence-specific DNA-binding protein. Science (1991) 6.60
Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen. Proc Natl Acad Sci U S A (1977) 6.57
A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev (1999) 6.34
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev (2000) 5.72
E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev (1998) 4.60
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev (1996) 3.98
Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol (1998) 3.61
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell (1991) 3.59
Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ (2006) 3.53
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell (2000) 3.41
Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev (1992) 3.37
PML is induced by oncogenic ras and promotes premature senescence. Genes Dev (2000) 3.35
The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell (1989) 3.01
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci U S A (1990) 2.77
Differential affinities of simian virus 40 large tumor antigen for DNA. Proc Natl Acad Sci U S A (1980) 2.75
Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev (1997) 2.70
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol (2001) 2.69
A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev (1993) 2.53
DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J (1999) 2.50
Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature (1995) 2.47
p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol (1999) 2.41
High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev (1998) 2.40
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev (1992) 2.29
Species-specific in vitro synthesis of DNA containing the polyoma virus origin of replication. Proc Natl Acad Sci U S A (1986) 2.16
Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell (1995) 2.13
The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U S A (1993) 2.11
The 400 kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Mol Cell (1998) 2.08
A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol (1996) 1.98
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene (2007) 1.97
Mutant p53 proteins bind DNA abnormally in vitro. Oncogene (1991) 1.96
p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol Cell Biol (2001) 1.93
A small subclass of SV40 T antigen binds to the viral origin of replication. Cell (1982) 1.86
DNA-binding properties of simian virus 40 T-antigen mutants defective in viral DNA replication. Mol Cell Biol (1983) 1.76
Different forms of simian virus 40 large tumor antigen varying in their affinities for DNA. J Virol (1982) 1.72
Discrete regions of simian virus 40 large T antigen are required for nonspecific and viral origin-specific DNA binding. J Virol (1982) 1.71
Assembly of functional U1 and U2 human-amphibian hybrid snRNPs in Xenopus laevis oocytes. Science (1988) 1.70
Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature (1996) 1.69
Splicing pathways of SV40 mRNAs in X. laevis oocytes differ in their requirements for snRNPs. Cell (1984) 1.69
Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells. J Virol (1978) 1.66
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol (1995) 1.63
At the crossroads of inflammation and tumorigenesis. J Exp Med (1999) 1.61
Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J (1999) 1.59
Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites. Cell (1987) 1.57
A role for p53 in base excision repair. EMBO J (2001) 1.56
p53 accumulates but is functionally impaired when DNA synthesis is blocked. Proc Natl Acad Sci U S A (2001) 1.55
p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res (1995) 1.47
Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev (1993) 1.45
U2 snRNA sequences that bind U2-specific proteins are dispensable for the function of U2 snRNP in splicing. Genes Dev (1989) 1.43
Alternative splicing of SV40 early pre-mRNA is determined by branch site selection. Genes Dev (1988) 1.42
In vitro splicing of simian virus 40 early pre mRNA. Nucleic Acids Res (1986) 1.40
Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1990) 1.39
P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation. Oncogene (2006) 1.37
The C-terminus of p53: the more you learn the less you know. Nat Struct Biol (2001) 1.34
Regulation of mutant p53 temperature-sensitive DNA binding. J Biol Chem (1996) 1.34
The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta (1994) 1.32
Simian virus 40 and polyomavirus large tumor antigens have different requirements for high-affinity sequence-specific DNA binding. J Virol (1985) 1.31
p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol Cell Biol (1997) 1.31
Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo. Mol Cell Biol (1996) 1.31
Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene (1998) 1.29
DNA binding and sedimentation properties of SV40 T antigens synthesized in vivo and in vitro. Cold Spring Harb Symp Quant Biol (1980) 1.27
Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites. EMBO J (1998) 1.26
Inhibition of viral protein synthesis in monkey cells treated with interferon late in simian virus 40 lytic cycle. Cell (1977) 1.25
DNA binding properties of simian virus 40 T-antigens synthesized in vivo and in vitro. J Virol (1980) 1.24
p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene (2006) 1.23
Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA. Mol Cell Biol (1997) 1.22
Covalent and noncovalent modifiers of the p53 protein. Cell Mol Life Sci (1999) 1.17
A role of cyclin G in the process of apoptosis. Oncogene (1999) 1.16
p53 responsive elements in human retrotransposons. Oncogene (2009) 1.15
Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen. J Virol (1990) 1.13
The DNA-binding properties of polyomavirus large T antigen are altered by ATP and other nucleotides. J Virol (1991) 1.10
Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Res (1996) 1.08
p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A. Mol Cell Biol (1996) 1.08
Helicase, DNA-binding, and immunological properties of replication-defective simian virus 40 mutant T antigens. J Virol (1989) 1.07
pBR322 DNA inhibits simian virus 40 gene expression in Xenopus laevis oocytes. Nucleic Acids Res (1987) 1.03
Simian virus 40 (SV40) T antigen binds specifically to double-stranded DNA but not to single-stranded DNA or DNA/RNA hybrids containing the SV40 regulatory sequences. J Virol (1988) 1.02
ATP induces the assembly of polyoma large tumor antigen into hexamers. Virology (1991) 1.02
The N terminus of p53 regulates its dissociation from DNA. J Biol Chem (2000) 1.02
Cyclin a-CDK phosphorylation regulates MDM2 protein interactions. J Biol Chem (2001) 1.01
A comparison of the translation of Mengo virus RNA and globin mRNA in krebs ascites cell-free extracts. FEBS Lett (1972) 1.00
p53 represses Sp1 DNA binding and HIV-LTR directed transcription. Cell Mol Biol (Noisy-le-grand) (1997) 0.99
DNA helicase and duplex DNA fragment unwinding activities of polyoma and simian virus 40 large T antigen display similarities and differences. J Biol Chem (1991) 0.99
p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner. Mol Cell Biol (1995) 0.99
An excised SV40 intron accumulates and is stable in Xenopus laevis oocytes. Genes Dev (1988) 0.98
Functional dissection of p53 tumor suppressor protein. Methods Enzymol (1997) 0.97
The replication functions of polyomavirus large tumor antigen are regulated by phosphorylation. J Virol (1993) 0.96
Association of simian virus 40 T antigen with the nuclear matrix of infected and transformed monkey cells. Mol Cell Biol (1984) 0.96
Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs. Nucleic Acids Res (1989) 0.96
Expression of polyomavirus large T antigen by using a baculovirus vector. J Virol (1987) 0.96
Phosphorylation and active ATP hydrolysis are not required for SV40 T antigen hexamer formation. J Biol Chem (1993) 0.94
DNA damage enables p73. Nature (1999) 0.94
Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins. Mol Cell Biol (2000) 0.93
Molecular biology. Getting p53 out of the nucleus. Science (2001) 0.93
Baculovirus p33 binds human p53 and enhances p53-mediated apoptosis. J Virol (1999) 0.92
Transcriptional regulation by p53 and p73. Cold Spring Harb Symp Quant Biol (2005) 0.91
Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus. Oncogene (2007) 0.91